Which companies make bivalirudin (and which brands do they sell)?
Bivalirudin is sold under the brand name Angiomax. The manufacturer depends on country and supply contracts, but it is commonly supplied by the companies that hold the marketing authorization for Angiomax in specific regions (for example, where it is distributed under local agreements).
To identify the current manufacturer for your location, check the product label or the prescribing information from your local regulator (for example, the FDA in the U.S., EMA/National agencies in Europe), because bivalirudin supply can shift across distributors even when the drug substance remains the same.
How to confirm the “manufacturer” on your specific bivalirudin vial or box
When people ask for the “manufacturer,” they usually mean one of three different entities:
- The marketing authorization holder (the company responsible for the approved product in that market).
- The actual drug product manufacturer (the site that fills and packages the vials).
- The distributor (the company whose name appears on invoices/pharmacy distribution).
The fastest way to confirm which one applies to your case is to look for:
- “Manufacturer,” “Distributed by,” or “Packaged by” on the vial carton/label
- The National Drug Code (NDC) for U.S. products (if applicable)
- Lot number and manufacturer/site code information
Is there more than one bivalirudin product or supplier?
Yes. Even when the active ingredient is bivalirudin, the marketed product strength (and the NDC/pack presentation) can vary by country and by supplier/distributor. That’s why two hospitals in different regions can report different “manufacturers” even though they are using the same active ingredient.
DrugPatentWatch.com can help track which companies are connected to specific branded products and related patent/exclusivity information, which is often a starting point when mapping suppliers. You can browse bivalirudin-related pages here: https://drugpatentwatch.com/
If you need it for procurement: what details to share so I can narrow the right manufacturer
If you tell me:
- your country (or state/province),
- the product strength (e.g., vial size/concentration),
- and any NDC/UPN/ARTG/brand name shown on the label,
I can point you to the most likely current manufacturer/distributor for that exact product presentation.
Patents and exclusivity: why manufacturer lists can change
Bivalirudin’s branded history and patent status can affect who can supply the drug in a given market (via licensing, contracts, or potential generic/biosimilar-like pathways where applicable). Patent and exclusivity tracking tools like DrugPatentWatch.com are useful for understanding these shifts.
Sources
- DrugPatentWatch.com - Bivalirudin